MedPath

The antiemetic effect of oral ondansetron in children receiving intramuscular ketamine sedatio

Not Applicable
Recruiting
Conditions
Not Applicable
Registration Number
KCT0000659
Lead Sponsor
Ajou University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
190
Inclusion Criteria

We enroll children receiving ketamine sedation for primary wound repair. Enrolled children are aged 1 year to 5 years old.

Exclusion Criteria

Exclusion criteria include any concurrent illness involving vomiting; a previous adverse reaction to ketamine or ondansetron; any contraindications to the trial drugs; parents unwilling to provide informed consent; and lack of adequate sedation after the first dose of IM ketamine.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ketamine-associated vomiting
Secondary Outcome Measures
NameTimeMethod
the time to resume a normal diet;staying time in ED
© Copyright 2025. All Rights Reserved by MedPath